115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and tumor microenvironmental characterization of HPV-negative invasive squamous cell carcinoma of the vulva
    Meeting Abstract

    Moufarrij, S.; Filippova, O.; Paula, A. D.; Heredia, J. B.; Leitao, M.; O'Cearbhaill, R.; Abu-Rustum, N.; Park, K.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Folate receptor positivity in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
    Meeting Abstract

    Manning-Geist, B.; Sullivan, M.; Zhou, Q.; Iasonos, A.; Stallworth, C.; Liu, Y.; Roche, K. L.; Gordhandas, S.; Chi, D.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Concurrent POLE hotspot mutations and mismatch repair deficiency in endometrial cancer: Defining cancer drivers
    Meeting Abstract

    Moufarrij, S.; Gazzo, A.; Selenica, P.; Abu-Rustum, N.; Ellenson, L.; Liu, Y.; Weigelt, B.; Momeni-Boroujeni, A.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Analysis of inactivating TSC1 and TSC2 alterations in a real-world patient population with advanced gynecologic cancers in the Foundation Medicine genomic database
    Meeting Abstract

    Dockery, L.; Richardson, D.; Neff, R.; Green, A.; Priebe, A.; Iyer, G.; Palma, N.; Navarro, W.; Moore, K.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Sensitivity of HER2-low uterine carcinosarcoma organoids to the antibody-drug conjugate, trastuzumab deruxtecan
    Meeting Abstract

    Moufarrij, S.; Dopeso, H.; Green, H.; Gill, K.; Brown, D.; Zammarrelli, W.; Varice, N.; Wu, M.; Paula, A. D.; de Oliveira, T. B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Lymph node metastases in endometrial cancer: A modern assessment in the era of sentinel lymph node mapping and molecular classification
    Meeting Abstract

    Praiss, A.; Dagher, C.; Zhou, Q.; Iasonos, A.; Rios-Doria, E.; Abu-Rustum, N.; Weigelt, B.; Ellenson, L.; Leitao, M.; Mueller, J.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Molecular subtypes and genomic landscape of undifferentiated and dedifferentiated endometrial cancer
    Meeting Abstract

    Dagher, C.; Selenica, P.; Momeni-Boroujeni, A.; Mueller, J.; Abu-Rustum, N.; Chui, H.; Weigelt, B.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Final overall survival data from a randomized, open-label, phase II study of relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel among patients with recurrent platinum-resistant ovarian cancer
    Meeting Abstract

    Colombo, N.; Van Gorp, T.; Matulonis, U.; Oaknin, A.; Grisham, R.; Provencher, D.; Fleming, G.; Olawaiye, A.; Pashova, H.; Tudor, I. C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Phase I analysis from the PYNNACLE phase I/II study of PC14586 in the subgroup of patients with advanced ovarian cancer harboring a TP53 Y220C mutation
    Meeting Abstract

    Schram, A.; Shapiro, G.; Thompson, J.; Vandross, A.; Kummar, S.; El-Khoueiry, A.; LeDuke, K.; Fellous, M.; Alland, L.; Dumbrava, E.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: Primary results of the phase III ENGOT-En9/LEAP-001 study
    Meeting Abstract

    Marth, C.; Moore, R.; Bidzinski, M.; Pignata, S.; Ayhan, A.; Rubio, M. J.; Beiner, M.; Hall, M.; Vulsteke, C.; Braicu, E. I.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save